News | Cardiac Diagnostics

Researchers have identified another reason to limit red meat consumption: high levels of a gut-generated chemical called trimethylamine N-oxide (TMAO) that is also linked to heart disease. Scientists found that people who eat a diet rich in red meat have triple the TMAO levels of those who eat a diet rich in either white meat or mostly plant-based proteins, but discontinuation of red meat eventually lowers those TMAO levels.

Home January 23, 2019
Home
An assortment of Boston Scientific AngioJet rheolytic thrombectomy catheters. These devices use high-velocity saline jets to entrain thrombus, resulting in microfragmentation and removal. Thrombectomy is also referred to as embolectomy.
Feature | Thrombectomy Devices | Dave Fornell, Editor

Catheter-based blood clot removal a decade ago was a standard of care for acute coronary revascularization, but declined ...

Home January 22, 2019
Home
News | Stents

The rise cardiovascular disease has been instrumental in fueling the coronary stent market share in the past few years ...

Home January 22, 2019
Home
News | Cardiovascular Ultrasound

January 21, 2019 – Medical experts have released “Guidelines for Performing a Comprehensive Transthoracic ...

Home January 21, 2019
Home
News | Cardiac Diagnostics

Meat-free athletes have already proven the performance-boosting power of a plant-based diet. Now, “Plant-Based Diets for Cardiovascular Safety and Performance in Endurance Sports,” a new scientific review published in the journal Nutrients1 adds further evidence that plant-based athletes benefit from improvements in heart health, performance and recovery.

Home January 21, 2019
Home
Seth Worley, M.D., senior consultant, section of cardiac electrophysiology, MedStar Heart and Vascular Institute, developed tools and techniques to optimize transvenous left ventricular (LV) lead implantation, including the I-CRT approach. Here he holds the tools that he personally developed for left ventricular lead implantation to treat heart failure. Photo courtesy of MedStar Heart and Vascular Institute at MedStar Washington Hospital Center.
Feature | EP Lab | Matthew S. McKillop, M.D., FACC, FHRS, and Seth J. Worley, M.D.

Interventional cardiac resynchronization therapy (I-CRT) describes the repurposing of a set of tools and techniques ...

Home January 21, 2019
Home
Technology

Abbott announced U.S. Food and Drug Administration (FDA) approval of the TactiCath Contact Force Ablation Catheter, Sensor Enabled, a new ablation catheter designed to help physicians accurately and effectively treat atrial fibrillation (AFib). The approval further expands Abbott's portfolio of cardiac ablation tools that integrate with the company's EnSite Precision cardiac mapping system to help physicians develop more precise images of the heart during cardiac ablation procedures.

Home January 21, 2019
Home
Technology | Angiography

Philips announced the launch of Azurion with FlexArm, designed to enhance positioning flexibility for image-guided procedures.

Home January 17, 2019
Home
This is 3-D blood flow view of blood flow through the chambers of a fetal heart using the GE Healthcare fetalHQ analysis software. #RSNA18 #RSNA #RSNA2018
Feature | RSNA | Dave Fornell, Editor

Many of the latest advances in cardiovascular imaging technologies are unveiled each year at the Radiological Society of ...

Home January 17, 2019
Home
News | Peripheral Artery Disease (PAD)

The U.S. Food and Drug Administration (FDA) issued a letter Jan. 17, 2019, to healthcare providers regarding a recent publication that suggests a possible increased risk of death at two years and beyond in patients treated for a type of peripheral artery disease (PAD) with paclitaxel-coated balloons or paclitaxel-eluting stents. The letter was issued in response to a recent publication in the Journal of the American Heart Association identifying the risk. It recommends doctors continue to monitor these patients, and discuss the benefits and risks of all available treatment options for patients with PAD.

Home January 17, 2019
Home
Artificial Intelligence in medical imaging was the top trend and buzz at RSNA 2018.
Feature | Artificial Intelligence | Dave Fornell, Editor

Artificial intelligence (AI) was by far the hottest trend discussed in sessions and across the expo floor at the world's ...

Home January 17, 2019
Home
Sponsored Content | Webinar | Information Technology

This webinar originally aired on February 6, 2019 and is now available for on-demand viewing. Register for this webinar ...

Home January 17, 2019
Home
News | Cardiovascular Information Systems (CVIS)

Philips announced that NewYork-Presbyterian Hospital has chosen to implement the company’s IntelliSpace Enterprise Edition solution across its hospitals and facilities. In a 10-year agreement, IntelliSpace Enterprise Edition will provide the health system with access to Philips’ full suite of informatics solutions across radiology, cardiology and analytics to help improve efficiencies and care delivery.

Home January 16, 2019
Home
News | Thrombectomy Devices

Cerenovus, of Johnson & Johnson Medical Devices Companies, recently launched the EXCELLENT Registry to collect and analyze stroke-inducing blood clots removed from the brain with its Embotrap II Revascularization Device. The company also announced European CE Mark approval for the Geometric Clot Extractor (GCE) Revascularization Device.

Home January 16, 2019
Home
News | Cath Lab

Shockwave Medical Inc. has initiated its U.S. Food and Drug Administration (FDA) Investigational Device Exemption (IDE) study – DISRUPT CAD III – for the use of intravascular lithotripsy (IVL) in heavily calcified coronary arteries. IVL is a lesion preparation tool designed to fracture problematic calcium using sonic pressure waves in order to facilitate stent delivery, deployment and expansion.

Home January 16, 2019
Home
Subscribe Now